Hobert JA, Eng C (2009) PTEN hamartoma tumor syndrome: an overview. Genet Med Oct 11(10):687–694

Article  CAS  Google Scholar 

Macken WL, Tischkowitz M, Lachlan KL (2019) PTEN Hamartoma tumor syndrome in childhood: a review of the clinical literature. Am J Med Genet C Semin Med Genet Dec 181(4):591–610

Article  Google Scholar 

Yehia L, Eng C (2020) PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation? Hum Mol Genet Oct 20(R2):R150–R157

Article  Google Scholar 

Ciaccio C, Saletti V, D’Arrigo S, Esposito S, Alfei E, Moroni I, Tonduti D, Chiapparini L, Pantaleoni C, Milani D (2019) Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur J Med Genet Dec 62(12):103596

Article  Google Scholar 

Yehia L, Ngeow J, Eng C (2019) PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest Feb 1(2):452–464

Article  Google Scholar 

Álvarez-Garcia V, Tawil Y, Wise HM, Leslie NR (2019) Mechanisms of PTEN loss in cancer: it’s all about diversity. Semin Cancer Biol Dec 59:66–79

Article  Google Scholar 

Leslie NR, Longy M (2016) Inherited PTEN mutations and the prediction of phenotype. Semin Cell Dev Biol Apr 52:30–38

Article  CAS  Google Scholar 

Zou Z, Tao T, Li H, Zhu X (2020) mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci Mar 10:10:31

Article  Google Scholar 

Jonker LA, Lebbink CA, Jongmans MCJ, Nievelstein RAJ, Merks JHM, van Nieveen EJM, Links TP, Hoogerbrugge N, van Trotsenburg ASP, van Santen HM (2020) Recommendations on surveillance for differentiated thyroid carcinoma in children with PTEN hamartoma tumor syndrome. Eur Thyroid J Sep 9(5):234–242

Article  CAS  Google Scholar 

Nasr Y, Bettoli M, El Demellawy D, Sekhon H, de Nanassy J (2019) Sclerosing pneumocytoma of the lungs arising in a child with PTEN mutation. Pediatr Dev Pathol Nov-Dec 22(6):579–583

Article  Google Scholar 

Plamper M, Born M, Gohlke B, Schreiner F, Schulte S, Splittstößer V, Woelfle J (2020) Cerebral MRI and clinical findings in children with PTEN hamartoma tumor syndrome: can cerebral MRI scan help to establish an earlier diagnosis of PHTS in Children? Cells Jul 10(7):1668

Article  Google Scholar 

Smpokou P, Fox VL, Tan WH (2015) PTEN hamartoma tumour syndrome: early tumour development in children. Arch Dis Child Jan 100(1):34–37

Article  Google Scholar 

Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res Jan 15(2):400–407

Article  Google Scholar 

Balci TB, Davila J, Lewis D, Boafo A, Sell E, Richer J, Nikkel SM, Armour CM, Tomiak E, Lines MA, Sawyer SL (2018) Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet Jan 177(1):101–109

Article  Google Scholar 

Dhamija R, Hoxworth JM (2020) Imaging of PTEN-related abnormalities in the central nervous system. Clin Imaging Apr 60(2):180–185

Article  Google Scholar 

Lok C, Viseux V, Avril MF, Richard MA, Gondry-Jouet C, Deramond H, Desfossez-Tribout C, Courtade S, Delaunay M, Piette F, Legars D, Dreno B, Saïag P, Longy M, Lorette G, Laroche L, Caux F, Cancerology Group of the French Society of Dermatology (2005) Brain magnetic resonance imaging in patients with Cowden syndrome. Med (Baltimore) Mar 84(2):129–136

Article  Google Scholar 

Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, Vento J, Chapman KA, Lanpher B, Pearl P, Gropman A, Lourenco C, Bamforth JS, Sharpe C, Pineda M, Schallner J, Bodamer O, Orcesi S, Oberstein SA, Sistermans EA, Yntema HG, Bonnemann C, Waldman AT, van der Knaap MS (2014) Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am J Med Genet Mar 164A(3):627–633

Article  Google Scholar 

Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N, Mahmoud HS, Mujtaba B, Stanietzky N, Elsayes KM (2021) PTEN Hamartoma Tumor Syndrome/Cowden Syndrome: Genomics, Oncogenesis, and Imaging Review for Associated Lesions and Malignancy. Cancers (Basel) Jun 22;13(13):3120

Golpanian S, Perez EA, Tashiro J, Lew JI, Sola JE, Hogan AR (2016) Pediatric papillary thyroid carcinoma: outcomes and survival predictors in 2504 surgical patients. Pediatr Surg Int Mar 32(3):201–208

Article  Google Scholar 

Baran JA, Tsai SD, Isaza A, Brodeur GM, MacFarland SP, Zelley K, Adams DM, Franco AT, Bauer AJ (2020) The clinical spectrum of PTEN hamartoma tumor syndrome: exploring the value of thyroid surveillance. Horm Res Paediatr 93(11–12):634–642

Article  CAS  PubMed  Google Scholar 

Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N, PHTS Guideline Development Group; European Reference Network GENTURIS (2020) Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet Oct 28(10):1387–1393

Article  Google Scholar 

Plitt G, Brewer T, Yehia L, Jin J, Shin J, Eng C (2022) Development and progression of thyroid disease in PTEN hamartoma tumor syndrome: refined surveillance recommendations. Thyroid Sep 32(9):1094–1100

Article  CAS  Google Scholar 

Guerra-Gutiérrez F, Torres Sánchez I, Gallardo-Madueño G, Mariño-Enríquez A, Nistal M (2007) Hemangioma Esclerosante pulmonar en un paciente con síndrome de Cowden [Pulmonary sclerosing hemangioma in a patient with Cowden syndrome]. Arch Bronconeumol Jul 43(7):418–420

Google Scholar 

Yalcin B, Bekci TT, Kozacioglu S, Bolukbas O (2019) Pulmonary sclerosing pneumocytoma, a rare tumor of the lung. Respir Med Case Rep Feb 13:26:285–287

Google Scholar 

Martin H, Bessis D, Bourrat E, Mazereeuw-Hautier J, Morice-Picard F, Balguerie X, Chiaverini C (2020) Cutaneous lipomas and macrocephaly as early signs of PTEN hamartoma tumor syndrome. Pediatr Dermatol Sep 37(5):839–843Groupe de Recherche de la Société Française de Dermatologie Pédiatrique

Kurek KC, Howard E, Tennant LB, Upton J, Alomari AI, Burrows PE, Chalache K, Harris DJ, Trenor CC 3rd, Eng C, Fishman SJ, Mulliken JB, Perez-Atayde AR, Kozakewich HP (2012) PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol May 36(5):671–687

Article  Google Scholar 

Gurunathan A, Ricci K, Iacobas I, Rednam SP, Wusik K, Fei L, Hammilll AM (2020) Impact of vascular anomalies on the PTEN phenotype in children and young adults. Pediatr Blood Cancer Jun 67(6):e28258

Article  Google Scholar 

Chism CB, Crawford L, Tchakarov A, Al-Ibraheemi A, Beckmann NM (2017) PTEN hamartoma of the soft tissue: the initial manifestation of an underlying PTEN hamartoma tumor syndrome in a 4-year-old female. Skeletal Radiol Nov 46(11):1591–1595

Article  Google Scholar 

https://www.issva.org/UserFiles/file/ISSVA-Classification-2018.pdf Accessed January 15, 2024

Farooq A, Walker LJ, Bowling J, Audisio RA (2010) Cowden syndrome. Cancer Treat Rev Dec 36(8):577–583

Article  CAS  Google Scholar 

Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, Woods CG, Fryns JP, Hamel B, Hoefsloot LH, Peeters EA, Padberg GW (1999) Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet Apr 7(3):267–273

Article  CAS  Google Scholar 

Yehia L, Eng C, PTEN Hamartoma Tumor Syndrome (2001). 2001 Nov 29 [Updated 2021 Feb 11]. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024. https://www.ncbi.nlm.nih.gov/books/NBK1488/

Plamper M, Gohlke B, Woelfle J (2022) PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline. Mol Cell Pediatr Feb 21;9(1):3

Yehia L, Plitt G, Tushar AM, Joo J, Burke CA, Campbell SC, Heiden K, Jin J, Macaron C, Michener CM, Pederson HJ, Radhakrishnan K, Shin J, Tamburro J, Patil S, Eng C (2023) Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. JAMA Netw Open Apr 36(4):e239705

Article  Google Scholar 

Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R, National comprehensive cancer network (2014) Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw Sep 12(9):1326–1338

Article  CAS  Google Scholar